Human In Motion Robotics Unveils 'XoMotion-R' at RehabWeek 2025

Venoty&R, a KOSDAQ-listed company led by CEO Jung Jibhun, announced on May 26 that its robotics subsidiary, Human In Motion Robotics, unveiled its next-generation rehabilitation wearable robot, XoMotion-R, at RehabWeek 2025, the world's largest rehabilitation technology conference, held in Chicago, United States, on May 12 (local time).

RehabWeek is the world's largest integrated academic event in the rehabilitation field, bringing together researchers, clinicians, engineers, and industry professionals from around the globe. The event began in Zurich, Switzerland, in 2011 and has been held biennially since then. It serves as a platform for sharing the latest technologies, including rehabilitation robots, and for fostering active collaboration among academia, industry, and research institutes.

Human In Motion Robotics participated in this event as an official sponsor and conducted demonstrations of XoMotion-R. The product attracted attention from experts in North America, Europe, Korea, and Australia as a rehabilitation robot based on humanoid technology, distinguished by its technological uniqueness and scalability. During the event, the company actively engaged with global rehabilitation experts and was invited to participate in several international academic conferences and events.

XoMotion-R is equipped with advanced self-balancing technology, allowing users to perform various movements such as walking and turning hands-free in a natural manner. It enables users to achieve a wide range of postures without the need for additional assistive devices, making it a groundbreaking solution in the field of rehabilitation therapy.

A representative from Human In Motion Robotics stated, "At this event, we received numerous inquiries about the launch and sale of XoMotion-R from representatives of major hospitals in Canada, the United Kingdom, and Germany, and related discussions are ongoing. Human In Motion Robotics will continue to expand global partnerships and drive continuous innovation in humanoid-based intelligent wearable robot technology to enhance mobility and independent living for users worldwide."

Meanwhile, Human In Motion Robotics is in the process of obtaining sales approval for XoMotion-R from the United States Food and Drug Administration (FDA) and the Korean Ministry of Food and Drug Safety. To this end, clinical trials and usability tests are being conducted simultaneously at Shirley Ryan AbilityLab of Northwestern University Feinberg School of Medicine in Chicago, Veterans Affairs Bronx Medical Center in New York, and university hospitals in Korea. In addition, the company recently entered into a strategic alliance with a local company in Singapore to accelerate its expansion into the ASEAN market and further grow its global business.

This content was produced with the assistance of AI translation services.